CS logo
small CS logo
Istituto Auxologico Italiano, Ospedale San Luca

Milano, Italy
Ospedale a Milano

About Istituto Auxologico Italiano, Ospedale San Luca


"Auxologico San Luca è l'ospedale di Auxologico che offre un'assistenza specializzata in particolare nei campi della cardiologia, neurologia, endocrinologia e malattie metaboliche, immunologia. Dotato di un Pronto Soccorso Cardiologico e Neurologico, di un’Unità di Terapia Intensiva Coronarica, una Stroke Unit, e di reparti ospedalieri di degenza, il San Luca garantisce un livello di assistenza che va dalla fase acuta (infarto, ictus e altri eventi cardiovascolari e cerebrovascolari) al trattamento riabilitativo. L’ospedale offre inoltre prestazioni ambulatoriali diagnostico-terapeutiche e un Punto Prelievi, accessibili sia privatamente sia in regime SSN."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Istituto Auxologico Italiano, Ospedale San Luca


During the past decade, Istituto Auxologico Italiano, Ospedale San Luca conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Auxologico Italiano, Ospedale San Luca" #1 collaborator was "Apnimed Inc." with 2 trials as a collaborator, "STM Pharma PRO srl" with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Philips Respironics" with 1 trials as a collaborator and "University of Florence" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

Clinical Trials Conditions at Istituto Auxologico Italiano, Ospedale San Luca


According to Clinical.Site data, the most researched conditions in "Istituto Auxologico Italiano, Ospedale San Luca" are "Heart Failure" (1 trials), "Long QT Syndrome" (1 trials), "Obesity Hypoventilation Syndrome (OHS)" (1 trials), "Obstructive Sleep Apnea" (1 trials) and "Sleep Apnea" (1 trials). Many other conditions were trialed in "Istituto Auxologico Italiano, Ospedale San Luca" in a lesser frequency.

Clinical Trials Intervention Types at Istituto Auxologico Italiano, Ospedale San Luca


Most popular intervention types in "Istituto Auxologico Italiano, Ospedale San Luca" are "Drug" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "AD128" (1 trials), "AD981" (1 trials), "Adaptive Servo Ventilation" (1 trials) and "Lumacaftor / Ivacaftor, Orkambi® Oral Tablet" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Istituto Auxologico Italiano, Ospedale San Luca


The vast majority of trials in "Istituto Auxologico Italiano, Ospedale San Luca" are 4 trials for "All" genders.

Clinical Trials Status at Istituto Auxologico Italiano, Ospedale San Luca


Currently, there are NaN active trials in "Istituto Auxologico Italiano, Ospedale San Luca". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Istituto Auxologico Italiano, Ospedale San Luca, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Auxologico Italiano, Ospedale San Luca, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".